LHX3: A Potential Drug Target for Tissues and Diseases (G8022)

Target Name: LHX3

NCBI ID: G8022

LHX3

LHX3: A Potential Drug Target for Tissues and Diseases

The protein LHX3, also known as LIM homeobox 3 or Transcript variant 2, is a gene that is located on chromosome 17 and is responsible for the development and maintenance of tissues in the body. LHX3 has been identified as a potential drug target and has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

The LHX3 gene is a member of the LIM gene family, which is known for its role in the development and maintenance of tissues in the body. The LIM gene family has been shown to play a role in the development and maintenance of a variety of tissues, including blood vessels, heart muscle, and neural cells.

LHX3 is a transmembrane protein, which means that it spans the cell membrane and is located in the cytoplasm. It is composed of four structural domains: an N-terminus, a transmembrane domain, a C-terminus, and a R-terminus. The N-terminus of LHX3 is located at the edge of the cell membrane and is responsible for the protein's ability to interact with the cell surface. The transmembrane domain is located in the middle of the protein and is responsible for the protein's ability to span the cell membrane. The C-terminus of LHX3 is located at the opposite end of the transmembrane domain and is responsible for the protein's ability to interact with its intracellular target. The R-terminus of LHX3 is located at the end of the protein and is responsible for the protein's ability to interact with its intracellular target.

LHX3 has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, LHX3 has been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. LHX3 has also been shown to be involved in the development and progression of cancer, and has been identified as a potential drug target for a variety of cancers, including breast, ovarian, and colorectal cancers.

In addition to its role in disease, LHX3 has also been shown to be a potential drug target. LHX3 has been shown to be involved in a variety of cellular processes, including cell adhesion, migration, and invasion. By targeting LHX3 with small molecules or other therapeutic agents, researchers may be able to interfere with its role in these processes and potentially treat a variety of diseases.

Overall, LHX3 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in the development and progression of disease and to identify potential therapeutic approaches.

Protein Name: LIM Homeobox 3

Functions: Transcription factor. Recognizes and binds to the consensus sequence motif 5'-AATTAATTA-3' in the regulatory elements of target genes, such as glycoprotein hormones alpha chain CGA and visual system homeobox CHX10, positively modulating transcription; transcription can be co-activated by LDB2. Synergistically enhances transcription from the prolactin promoter in cooperation with POU1F1/Pit-1 (By similarity). Required for the establishment of the specialized cells of the pituitary gland and the nervous system (PubMed:21149718). Involved in the development of interneurons and motor neurons in cooperation with LDB1 and ISL1 (By similarity)

The "LHX3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LHX3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets